Articles with public access mandates - Husen M. UmerLearn more
Available somewhere: 14
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
Mandates: US National Institutes of Health, Danish Council for Independent Research …
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
J Lehtiö, T Arslan, I Siavelis, Y Pan, F Socciarelli, O Berkovska, HM Umer, ...
Nature cancer 2 (11), 1224-1242, 2021
Mandates: Swedish Research Council, UK Medical Research Council, Worldwide Cancer …
A significant regulatory mutation burden at a high‐affinity position of the CTCF motif in gastrointestinal cancers
HM Umer, M Cavalli, MJ Dabrowski, K Diamanti, M Kruczyk, G Pan, ...
Human mutation 37 (9), 904-913, 2016
Mandates: Swedish Research Council
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
SA Herbst, M Vesterlund, AJ Helmboldt, R Jafari, I Siavelis, M Stahl, ...
Nature Communications 13 (1), 6226, 2022
Mandates: US National Institutes of Health, German Research Foundation, Knut and Alice …
Allele specific chromatin signals, 3D interactions, and motif predictions for immune and B cell related diseases
M Cavalli, N Baltzer, HM Umer, J Grau, I Lemnian, G Pan, O Wallerman, ...
Scientific reports 9 (1), 2695, 2019
Mandates: German Research Foundation, Swedish Research Council
Generation of ENSEMBL-based proteogenomics databases boosts the identification of non-canonical peptides
HM Umer, E Audain, Y Zhu, J Pfeuffer, T Sachsenberg, J Lehtiö, ...
Bioinformatics 38 (5), 1470-1472, 2022
Mandates: National Natural Science Foundation of China, Wellcome Trust, Federal …
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy
K Peltonen, S Feola, HM Umer, J Chiaro, G Mermelekas, E Ylösmäki, ...
Cancers 13 (14), 3408, 2021
Mandates: Swedish Research Council, European Commission
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
S Stratmann, M Vesterlund, HM Umer, S Eshtad, A Skaftason, MK Herlin, ...
Leukemia 37 (3), 550-559, 2023
Mandates: Knut and Alice Wallenberg Foundation, Swedish Research Council
Maps of context-dependent putative regulatory regions and genomic signal interactions
K Diamanti, HM Umer, M Kruczyk, MJ Dąbrowski, M Cavalli, C Wadelius, ...
Nucleic Acids Research 44 (19), 9110-9120, 2016
Mandates: Swedish Research Council
Glioblastoma stem cells express non‐canonical proteins and exclusive mesenchymal‐like or non‐mesenchymal‐like protein signatures
H Babačić, S Galardi, HM Umer, M Hellström, L Uhrbom, N Maturi, ...
Molecular Oncology 17 (2), 238-260, 2023
Mandates: European Commission
Functional annotation of noncoding mutations in cancer
HM Umer, K Smolinska, J Komorowski, C Wadelius
Life science alliance 4 (9), 2021
Mandates: National Science Centre, Poland
Proteogenomics analysis of human tissues using pangenomes
D Wang, R Bouwmeester, P Zheng, C Dai, AS Puente, K Shu, M Bai, ...
bioRxiv, 2024.05. 24.595489, 2024
Mandates: Wellcome Trust
Proteogenomic Subtyping of Chronic Lymphocytic Leukemia Identifies a Novel Poor Outcome Subgroup with a Distinct Drug Response Profile
SA Herbst, M Vesterlund, R Jafari, I Siavelis, M Stahl, E Schitter, ...
Blood 136, 10-11, 2020
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
Publication and funding information is determined automatically by a computer program